JW Pharmaceuticals - Crunchbase Company Profile & Funding

Overview

JW Pharmaceuticals

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About JW Pharmaceuticals

CB Rank

262107

JW Pharmaceuticals is a company that provides medical products and quasi drugs.

Founded

obfuscation

Private

Seoul, Seoul-t'ukpyolsi, South Korea

1001-5000

www.jw-pharma.co.kr/pharma/ko/main.jsp

Biotechnology

Health Care

Manufacturing

Medical

Pharmaceutical

Key People

Young Sub Shin: CEO

Details

Also Known As

JW중외제약

Operating Status

Active

Number of Exits

obfuscation

Company Type

For Profit

Phone Number

02-840-6777

Predictions & Insights

Growth Insight

See this Growth Insight

JW Pharmaceuticals is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Products & Services

Ertapenem

An antibiotic used to treat bacterial infections by inhibiting bacterial cell wall synthesis.

Dr. Lamine Intravenous Amino Acid Solution 200mL

An intravenous amino acid solution designed to supplement essential amino acids for patient recovery and nutrition.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Investments

Investment Breakdown

Number of Investments

Number of Exits

obfuscation

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Progen	—	Post-IPO Equity - Progen	obfuscated obfuscation
obfuscated obfuscation	Progen	—	Post-IPO Equity - Progen	obfuscated obfuscation
obfuscated obfuscation	Progen	—	Post-IPO Equity - Progen	obfuscated obfuscation
obfuscated obfuscation	Progen	—	Post-IPO Equity - Progen	obfuscated obfuscation
obfuscated obfuscation	Progen	—	Post-IPO Equity - Progen	obfuscated obfuscation

Investment Breakdown

Number of Investments

Number of Exits

obfuscation

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Progen	—	Post-IPO Equity - Progen	obfuscated obfuscation
obfuscated obfuscation	Progen	—	Post-IPO Equity - Progen	obfuscated obfuscation
obfuscated obfuscation	Progen	—	Post-IPO Equity - Progen	obfuscated obfuscation
obfuscated obfuscation	Progen	—	Post-IPO Equity - Progen	obfuscated obfuscation
obfuscated obfuscation	Progen	—	Post-IPO Equity - Progen	obfuscated obfuscation